Literature DB >> 1792467

Subacute sclerosing panencephalitis in England and Wales: transient effects and risk estimates.

C P Farrington1.   

Abstract

Data on cases of subacute sclerosing panencephalitis (SSPE) with onset in 1970-89 show a marked increase in the interval from initial measles attack to onset of SSPE by year of onset. It is shown that this increase is a transient effect resulting from the decline in measles incidence following the introduction of mass vaccination in 1968. The risk of SSPE after measles is estimated to be 4.0 x 10(-5) (18 x 10(-5) after measles under one year of age) and the risk after vaccination to be no greater than 0.14 x 10(-5), thus confirming that vaccination is effective in reducing the incidence of SSPE. The paper makes use of methods developed to estimate the incubation period of AIDS.

Entities:  

Mesh:

Year:  1991        PMID: 1792467     DOI: 10.1002/sim.4780101111

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Rapid neurological deterioration in a 22-year-old man.

Authors:  M O McCarron; G V McDonnell; J M Gibson
Journal:  Postgrad Med J       Date:  1997-06       Impact factor: 2.401

2.  The Swiss Paediatric Surveillance Unit (SPSU).

Authors:  H Zimmermann; D Desgrandchamps; G Schubiger
Journal:  Soz Praventivmed       Date:  1995

3.  The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.

Authors:  C Miller; N Andrews; M Rush; H Munro; L Jin; E Miller
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

4.  Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.

Authors:  Laurens Manning; Moses Laman; Henry Edoni; Ivo Mueller; Harin A Karunajeewa; David Smith; Ilomo Hwaiwhanje; Peter M Siba; Timothy M E Davis
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

5.  The average cost of measles cases and adverse events following vaccination in industrialised countries.

Authors:  Hélène Carabin; W John Edmunds; Ulla Kou; Susan van den Hof; Van Hung Nguyen
Journal:  BMC Public Health       Date:  2002-09-19       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.